Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Abbott to supply over 1 million COVID-19 antibody tests to India

Ruchika Sharma23 Jun 2020 11:00 AM IST

Abbott said it is already in the process of delivering antibody tests to leading government and private hospitals and labs in Maharashtra, Delhi, West...

COVID-19: Chinese researchers launch phase 2 of vaccine trial on humans

Ruchika Sharma23 Jun 2020 9:15 AM IST

About a dozen vaccines are in different stages of human tests globally, as the World Health Organization warns the coronavirus pandemic is...

COVID-19: Cipla launches remdesivir under brand name Cipremi in India

Ruchika Sharma22 Jun 2020 4:17 PM IST

Cipla has been granted regulatory approval by the Drug Controller General of India (DCGI) for restricted emergency use in the country as part of the...

Abacavir, Dolutegravir and Lamivudine Tablets for Oral Suspension

Lupin, Unichem recall BP drugs in US over quality issue

Ruchika Sharma22 Jun 2020 12:02 PM IST

The Class-II recall is on account of "Product Mix Up: Lisinopril 10 mg tablets were found in Lisinopril 5 mg 1000-count bottle," the report said.

Cipla, Hetero Labs secure DCGI nod for Remdesivir to treat COVID cases

Ruchika Sharma22 Jun 2020 11:01 AM IST

The drug, administered in the form of injection, should be given at a dose of 200 mg on day one followed by 100 mg daily for five days.

Sanofi-Regeneron Dupixent gets NMPA nod to treat atopic dermatitis

Ruchika Sharma22 Jun 2020 10:30 AM IST

The approval was based on positive data from the global LIBERTY AD clinical trial program that included nearly 3,000 patients with inadequately...

Covid-19 Crisis: SCO Secretary-General Lauds India For Supplying Medicines to 133 countries

Ruchika Sharma22 Jun 2020 9:45 AM IST

India has so far supplied medicines to 133 countries in the fight against Covid-19, which shows India's generosity, despite the fact that the...

Entresto Patent Expiry to Weigh on Novartis as Profit Seen Falling in 2026

Novartis India net profit falls 65pc to Rs 6.78 crore in Q4

Ruchika Sharma22 Jun 2020 9:30 AM IST

Revenue from operations stood at Rs 93.70 crore for the quarter under consideration. It was Rs 110.38 crore for the same period a year ago, Novartis...

CDSCO issues Clarification on import of diagnostic kits, reagents for Research Use Only

Ruchika Sharma21 Jun 2020 2:30 PM IST

New Delhi: Through a recent notification, Central Drugs Standard Control Organization(CDSCO)(Medical Devices Division), Directorate General of Health...

Fortis Healthcare posts Q4 net loss of Rs 41 crore

Ruchika Sharma21 Jun 2020 1:30 PM IST

New Delhi: Fortis Healthcare on Wednesday reported a consolidated net loss of Rs 41.24 crore for the quarter ended March 31, 2020.The company had...

Piramal Pharma Solutions acquires G&W Labs Sellersville facility

Ruchika Sharma21 Jun 2020 11:30 AM IST

Mumbai: Piramal Enterprises Limited's (PEL) Pharma Solutions business, a Contract Development and Manufacturing Organization (CDMO) has announced that...

Roche Itovebi recommended by CHMP for EU approval for PIK3CA-mutated, ER-positive, HER2-negative, advanced breast cancer

Roche, Entero Healthcare join hands for key nephrology drugs

Ruchika Sharma21 Jun 2020 11:00 AM IST

Under this agreement, Entero will be responsible for promotion, marketing and distribution of Roche Pharma’s key nephrology drugs viz., Mycophenolate...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok